Liminatus Pharma Stock (NASDAQ:LIMN)
Previous Close
$6.65
52W Range
$4.40 - $33.66
50D Avg
$10.55
200D Avg
$10.55
Market Cap
$164.67M
Avg Vol (3M)
$357.72K
Beta
0.17
Div Yield
-
LIMN Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.